Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)

Trading Overview

  • Last closing price: CNH 7.78
  • 24‑hour change: 0 % (flat)
  • Volume traded in last 24 h: CNH 102.6 million
  • Total shares outstanding: 2 billion
  • Market capitalisation: CNH 15.3 billion
  • Simple moving average (200 days): CNH 8.03
  • 52‑week high: CNH 10.67 (15 April 2026)
  • 52‑week low: CNH 7.16 (22 June 2026)

Recent Shareholder Activity

  • Institutional ownership declined at the end of the third quarter.
  • Three institutional investors disclosed holdings totaling approximately 6.94 million shares, representing 17 % of the total share capital.
  • This reflects a drop of about two percentage points compared with the previous quarter.
  • Institutional holders include Tonghua Dongbao Pharmaceutical itself, Tibet Trust, and Hong Kong Central Clearing.
  • Share price remained stable amid the change in ownership structure.
  • No additional commentary on earnings or strategic developments was provided.

Context within the Sector

  • The company trades in the same segment as other healthcare and pharmaceutical firms listed on the Shanghai Stock Exchange.
  • Its performance is monitored in comparison with peers such as Lakala Payment, Chagee, Huaming Power Equipment, Guangzhou Haozhi Industria, and Hangzhou Diagens Biotechno‑h, though those firms operate in different sectors (payment services, engineering, power equipment, industrial, biotechnology).
  • Recent market reports focus on broader movements in the Chinese market, sector‑specific activity such as MLCC and robotics, and the performance of other listed firms; no direct operational updates for Tonghua Dongbao Pharmaceutical were cited.

Company Profile

Tonghua Dongbao Pharmaceutical Co., Ltd. is headquartered in Tonghua, China. The company manufactures and markets Western medicines, Chinese medicines, biological products, and plastic building materials.